多发性硬化症的临床概况:沿着疾病持续时间的认知储备和运动损伤
Sabrina Maffezzini1, Veronica Pucci2,3, Alice Riccardi1
1Multiple Sclerosis Centre, University-Hospital of Padua, 35128 Padova, Italy.
Behavioral sciences (Basel, Switzerland)
|September 27, 2023
概括
认知储备 (CR) 在多发性硬化症 (MS) 中显著影响认知功能. 较高的CR可以保持认知表现,即使疾病持续时间长,除非运动残疾严重.
科学领域:
- 神经科学是一个神经科学.
- 临床神经学 临床神经学
- 心理学 心理学 心理学
背景情况:
- 认知障碍是多发性硬化症 (MS) 的一个重要问题.
- 以前的研究将MS认知功能与临床变量和认知储备 (CR) 联系起来.
- 在MS中保持神经心理功能时,临床因素和CR之间的相互作用未得到充分研究.
研究的目的:
- 研究一种假设,即较高的认知储备 (CR) 预测了MS患者更好的认知效率.
- 检查CR如何调节临床变量 (疾病持续时间,运动残疾) 对MS认知表现的影响.
主要方法:
- 一组100名多发性硬化症患者 (30-74岁) 参与了这项研究.
- 远程评估包括CR问卷和认知查测试.
- 在数据分析中使用了通用添加模型.
主要成果:
- 认知性能差异的很大一部分是由CR和疾病持续时间,CR和运动残疾之间的相互作用解释的.
- 较高的CR水平与更好的认知表现有关,即使存在长时间的疾病持续时间.
- 当运动残疾严重时,CR的这种保护作用会减弱.
结论:
- 认知储备 (CR) 在患有多发性硬化症的个体中,在维持认知功能方面发挥着关键作用.
- CR可以减轻疾病持续时间对认知的负面影响,但严重的运动残疾限制了这一点.
相关概念视频
Cognitive Development During Adulthood
142
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
142
Parkinson's Disease: Overview
590
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
590
Alzheimer's Disease: Overview
513
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
513


